NYSE: SOLVSolventum Corp Stock
$77.31+0.42 (+0.55%)
Updated Nov 19, 2025
SOLV Price
$77.31
Fair Value Price
N/A
Market Cap
$13.41B
52 Week Low
$60.70
52 Week High
$85.92
P/E
8.84x
P/B
2.69x
P/S
1.51x
PEG
N/A
Dividend Yield
N/A
Revenue
$8.40B
Earnings
$1.52B
Gross Margin
54.1%
Operating Margin
24.66%
Profit Margin
18.1%
Debt to Equity
1.8
Operating Cash Flow
$493M
Beta
0.83
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SOLV's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
A
SOLV
Ranked#13 of 44
Ranked#13 of 44
Be the first to know about important SOLV news, forecast changes, insider trades & much more!
SOLV News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SOLV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SOLV is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SOLV is good value based on its earnings relative to its share price (8.84x), compared to the US market average (43.97x)
P/E vs Market Valuation
SOLV is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more SOLV due diligence checks available for Premium users.
Valuation
SOLV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
8.84x
Industry
41.4x
Market
43.97x
SOLV is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SOLV is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SOLV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.69x
Industry
3.94x
SOLV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SOLV's financial health
Profit margin
Revenue
$2.1B
Net Income
$1.3B
Profit Margin
60.4%
SOLV's Earnings (EBIT) of $2.07B... subscribe to Premium to read more.
Interest Coverage Financials
SOLV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$14.0B
Liabilities
$9.0B
Debt to equity
1.8
SOLV's short-term assets ($4.41B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SOLV's long-term liabilities ($6.05B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SOLV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$76.0M
Investing
$3.8B
Financing
-$2.7B
SOLV's operating cash flow ($493.00M)... subscribe to Premium to read more.
Debt Coverage Financials
SOLV vs Health Information Service Stocks
Solventum Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.